NewEdge Wealth LLC Buys Shares of 5,030 Agilent Technologies, Inc. $A

NewEdge Wealth LLC bought a new position in Agilent Technologies, Inc. (NYSE:A – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 5,030 shares of the medical research company’s stock, valued at approximately $668,000.

Several other hedge funds also recently modified their holdings of A. Brighton Jones LLC lifted its stake in shares of Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. Jones Financial Companies Lllp increased its position in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares during the last quarter. Geneos Wealth Management Inc. raised its holdings in Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after buying an additional 212 shares in the last quarter. Acadian Asset Management LLC raised its holdings in Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after buying an additional 758 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Agilent Technologies in the second quarter worth about $273,000.

Get Agilent Technologies alerts:

Agilent Technologies Stock Up 1.9%

A stock opened at $159.25 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.51. The company has a 50-day moving average of $137.57 and a two-hundred day moving average of $126.23. The stock has a market capitalization of $44.98 billion, a price-to-earnings ratio of 31.98, a price-to-earnings-growth ratio of 2.81 and a beta of 1.25.

Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm’s revenue was up 10.0% compared to the same quarter last year. During the same period last year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Analyst Upgrades and Downgrades

A has been the subject of several recent analyst reports. Sanford C. Bernstein initiated coverage on Agilent Technologies in a research note on Friday, June 26th. They set an “outperform” rating and a $155.00 price target for the company. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Jefferies Financial Group started coverage on Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price for the company. Barclays upped their target price on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. Finally, Morgan Stanley lifted their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $160.24.

View Our Latest Stock Analysis on Agilent Technologies

Agilent Technologies Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Read More

• Five stocks we like better than Agilent Technologies
• 2 Biotech Stocks Shaping Up for Major Breakouts
• 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
• 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
• Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.